Although the pro-oncogene role of PDIA5 in cancers has been reported previously, our study revealed another regulatory effect that PDIA5 plays in GBM cells, through the promotion of the expression of the protein CCAR1. This evidence concerns the gene CCAR1 and glioblastoma.